Literature DB >> 23365086

A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.

Hisashi Oishi1, Takahito Tsubaki, Tatsuhiko Miyazaki, Masao Ono, Masato Nose, Satoru Takahashi.   

Abstract

Systemic lupus erythematosus is considered to be under the control of polygenic inheritance, developing according to the cumulative effects of susceptibility genes with polymorphic alleles; however, the mechanisms underlying the roles of polygenes based on functional and pathological genomics remain uncharacterized. In this study, we substantiate that a CD72 polymorphism in the membrane-distal extracellular domain impacts on both the development of glomerulonephritis and vasculitis in a lupus model strain of mice, MRL/MpJ-Fas(lpr), and the reactivity of BCR signal stimulation. We generated mice carrying a bacterial artificial chromosome transgene originating from C57BL/6 (B6) mice that contains the Cd72(b) locus (Cd72(B6) transgenic [tg]) or the modified Cd72(b) locus with an MRL-derived Cd72(c) allele at the polymorphic region corresponding to the membrane-distal extracellular domain (Cd72(B6/MRL) tg). Cd72(B6) tg mice, but not Cd72(B6/MRL) tg mice, showed a significant reduction in mortality following a marked improvement of disease associated with decreased serum levels of IgG3 and anti-dsDNA Abs. The number of splenic CD4(-)CD8(-) T cells in Cd72(B6) tg mice was decreased significantly in association with a reduced response to B cell receptor signaling. These results indicate that the Cd72 polymorphism affects susceptibility to lupus phenotypes and that novel functional rescue by a bacterial artificial chromosome transgenesis is an efficient approach with wide applications for conducting a genomic analysis of polygene diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23365086      PMCID: PMC3575566          DOI: 10.4049/jimmunol.1202196

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice.

Authors:  D Zeng; M K Lee; J Tung; A Brendolan; S Strober
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation.

Authors:  C Pan; N Baumgarth; J R Parnes
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

3.  Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus.

Authors:  C M Grimaldi; D J Michael; B Diamond
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

Review 4.  Finding genes that underlie complex traits.

Authors:  Anne M Glazier; Joseph H Nadeau; Timothy J Aitman
Journal:  Science       Date:  2002-12-20       Impact factor: 47.728

5.  Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response.

Authors:  S Santulli-Marotto; Y Qian; S Ferguson; S H Clarke
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

6.  Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses.

Authors:  Yan Xiu; Kazuhiro Nakamura; Masaaki Abe; Na Li; Xiang Shu Wen; Yi Jiang; Danqing Zhang; Hiromichi Tsurui; Shuji Matsuoka; Yoshitomo Hamano; Hiroyuki Fujii; Masao Ono; Toshiyuki Takai; Toshibumi Shimokawa; Chisei Ra; Toshikazu Shirai; Sachiko Hirose
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

7.  Arthritis in MRL/lpr mice is under the control of multiple gene loci with an allelic combination derived from the original inbred strains.

Authors:  Junji Kamogawa; Miho Terada; Shinichi Mizuki; Miyuki Nishihara; Haruyasu Yamamoto; Shiro Mori; Yoriko Abe; Koji Morimoto; Syuichi Nakatsuru; Yusuke Nakamura; Masato Nose
Journal:  Arthritis Rheum       Date:  2002-04

8.  Genetic dissection of vasculitis in MRL/lpr lupus mice: a novel susceptibility locus involving the CD72c allele.

Authors:  W M Qu; T Miyazaki; M Terada; L M Lu; M Nishihara; A Yamada; S Mori; Y Nakamura; H Ogasawara; C Yazawa; S Nakatsuru; M Nose
Journal:  Eur J Immunol       Date:  2000-07       Impact factor: 5.532

9.  A new method for generating point mutations in bacterial artificial chromosomes by homologous recombination in Escherichia coli.

Authors:  M Lalioti; J Heath
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

10.  Generating transgenic mice from bacterial artificial chromosomes: transgenesis efficiency, integration and expression outcomes.

Authors:  Margaret L Van Keuren; Galina B Gavrilina; Wanda E Filipiak; Michael G Zeidler; Thomas L Saunders
Journal:  Transgenic Res       Date:  2009-04-26       Impact factor: 2.788

View more
  4 in total

1.  CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases : English version.

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 2.  [CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version].

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

3.  CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP.

Authors:  Chizuru Akatsu; Kenro Shinagawa; Nobutaka Numoto; Zhihong Liu; Ayse Konuskan Ucar; Mohammad Aslam; Shirly Phoon; Takahiro Adachi; Koji Furukawa; Nobutoshi Ito; Takeshi Tsubata
Journal:  J Exp Med       Date:  2016-10-24       Impact factor: 14.307

4.  Trib1 Is Overexpressed in Systemic Lupus Erythematosus, While It Regulates Immunoglobulin Production in Murine B Cells.

Authors:  Léa Simoni; Virginia Delgado; Julie Ruer-Laventie; Delphine Bouis; Anne Soley; Vincent Heyer; Isabelle Robert; Vincent Gies; Thierry Martin; Anne-Sophie Korganow; Bernardo Reina-San-Martin; Pauline Soulas-Sprauel
Journal:  Front Immunol       Date:  2018-03-15       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.